Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-05

Clinical Trial Update: Iron Sucrose in Stage 3/4 Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial of iron sucrose for anemia in stage 3-4 chronic kidney disease has completed. The study was sponsored by Melbourne Health.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iron sucrose (iron sucrose)

Snippet

Sponsor: Melbourne Health | Conditions: Kidney Failure, Anemia | Phase 3 | Status: COMPLETED